ConductScience.org, home
A Study to Evaluate Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis
API referenceFor AI assistants

Trial · NCT03568318

Participant flow24

How many started, completed or left each group, period by period.

1 to 20 of 24

Download this page as JSON
PeriodMilestoneGroupParticipantsUnits counted
Overall StudySTARTEDAdults: Placebo + Topical Corticosteroids264
Overall StudySTARTEDAdults: Upadacitinib 15 mg + Topical Corticosteroids261
Overall StudySTARTEDAdults: Upadacitinib 30 mg + Topical Corticosteroids260
Overall StudySTARTEDAdolescents: Placebo + Topical Corticosteroids63
Overall StudySTARTEDAdolescents: Upadacitinib 15 mg + Topical Corticosteroids60
Overall StudySTARTEDAdolescents: Upadacitinib 30 mg + Topical Corticosteroids60
Overall StudyReceived Study DrugAdults: Placebo + Topical Corticosteroids264
Overall StudyReceived Study DrugAdults: Upadacitinib 15 mg + Topical Corticosteroids261
Overall StudyReceived Study DrugAdults: Upadacitinib 30 mg + Topical Corticosteroids260
Overall StudyReceived Study DrugAdolescents: Placebo + Topical Corticosteroids62
Overall StudyReceived Study DrugAdolescents: Upadacitinib 15 mg + Topical Corticosteroids60
Overall StudyReceived Study DrugAdolescents: Upadacitinib 30 mg + Topical Corticosteroids60
Overall StudyCOMPLETEDAdults: Placebo + Topical Corticosteroids244
Overall StudyCOMPLETEDAdults: Upadacitinib 15 mg + Topical Corticosteroids249
Overall StudyCOMPLETEDAdults: Upadacitinib 30 mg + Topical Corticosteroids250
Overall StudyCOMPLETEDAdolescents: Placebo + Topical Corticosteroids59
Overall StudyCOMPLETEDAdolescents: Upadacitinib 15 mg + Topical Corticosteroids58
Overall StudyCOMPLETEDAdolescents: Upadacitinib 30 mg + Topical Corticosteroids60
Overall StudyNOT COMPLETEDAdults: Placebo + Topical Corticosteroids20
Overall StudyNOT COMPLETEDAdults: Upadacitinib 15 mg + Topical Corticosteroids12

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Next page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03568318/flow

API referenceFor AI assistants